Status:
UNKNOWN
Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer
Lead Sponsor:
Peking University People's Hospital
Conditions:
Immune Microenvironment
Luminal A
Eligibility:
FEMALE
Brief Summary
Luminal type A breast cancer is a type with good clinical prognosis, and the proportion of lymph node metastasis is low, but a small number of patients have more lymph node metastasis when the primary...
Eligibility Criteria
Inclusion
- invasive breast cancer with Luminal A type;T1 with positive lymph node or T2/T3 with negative lymph node
Exclusion
- Missing specimen
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04322331
Start Date
May 1 2020
End Date
December 31 2021
Last Update
March 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking university people's hospital
Beijing, China